Dr. Alyssa R. Hoverson Schott, MD

Dr. Hoverson Schott practices at Sanford 1717 Medical Building in East Grand Forks, Minnesota.

Dr. Hoverson Schott's NPI, 1982613246, was assigned on August 5, 2006. Dr. Hoverson Schott graduated from University of North Dakota School of Medicine in 2005. Dr. Hoverson Schott holds Minnesota license MN-48913.

Dr. Hoverson Schott's primary practice is Sanford 1717 Medical Building, at 625 Demers Ave, East Grand Forks, MN 56721 in Polk County. The practice phone is (701) 234-4445.

Dr. Hoverson Schott's primary practice is Sanford 1717 Medical Building in East Grand Forks, Minnesota. Dr. Hoverson Schott is also affiliated with Sanford Broadway Medical Center. The medical group on file is Sanford West Fargo Clinic. Dmand AI also links Dr. Hoverson Schott to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hoverson Schott practices, 5 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Hoverson Schott's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dmand AI has Dr. Hoverson Schott's licenses on file in 3 states: Minnesota, Arizona and North Dakota.

CMS data shows 6,431 Medicare services from Dr. Hoverson Schott across 43 procedure codes in 2024, for 614 Medicare patients. Medicare paid $671,508 for them. Every service was in an office.

CMS counts 614 Medicare patients who saw Dr. Hoverson Schott in 2024. The largest group is 65 to 74, with 257 patients. 72% of them have high cholesterol, and 70% have high blood pressure. 3% are also on Medicaid. Their average risk score is 1.02, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Hoverson Schott's median patient age at 71, with 53% women.

In 2024, Dr. Hoverson Schott wrote 610 Medicare Part D claims for 305 patients. 96% of them were for generic drugs. CMS names the drug for 462 of them, across 9 drugs with 11 or more claims each, at $6,124 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Hoverson Schott for performance year 2024, reported as part of a group. Dr. Hoverson Schott accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 824 procedures of removal or shaving of skin growth by Dr. Hoverson Schott, more than 98% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Hoverson Schott. Dr. Hoverson Schott's most frequent co-authors are Jerry D. Brewer, MD and Randall K. Roenigk, MD.

CMS Open Payments shows 14 general payments to Dr. Hoverson Schott from 4 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Kerecis Limited paid the most, $373.

Dr. Hoverson Schott graduated from University of North Dakota School of Medicine in 2005.